Scientist.com Launches Agentic AI Platform for Research Procurement

Published on
October 22, 2026

SOLANA BEACH, Calif.--(BUSINESS WIRE)--Scientist.com, the leading R&D orchestration platform and marketplace, today announced new agentic AI capabilities that enable scientists to move directly from experimental protocols to qualified laboratory providers and purchase orders. The platform uses AI agents to identify required services, match suitable laboratories, compare proposals, and manage purchasing through existing enterprise procurement workflows. Through Model Context Protocol (MCP), Scientist.com enables external AI assistants, such as Claude, to discover suppliers and initiate research procurement workflows directly.

From Scientific Protocol to Qualified Laboratory

Scientist.com's agentic platform simplifies the research procurement process:

  • Analyze uploaded protocols to identify required laboratory services and capabilities
  • Match those requirements across a network of qualified laboratories
  • Receive and compare multiple proposals side-by-side, with AI assistance
  • Turn selected proposals into orders while applying organizational purchasing policies

Researchers can also initiate purchasing workflows by entering a simple description of their needs, uploading an existing supplier quote, or referring to a previous purchase they want to repeat.

What sets Scientist.com apart is the infrastructure behind the AI. Its established global network includes more than 6,000 qualified suppliers already covered by existing legal agreements. This allows AI agents to move beyond supplier recommendations to initiate real transactions without the delays associated with traditional supplier onboarding and contracting.

“Scientists should spend their time designing experiments and advancing discoveries, not finding laboratories and navigating procurement,” said Diana Ourthiague, PhD, CCO at Scientist.com. “We're connecting scientific intent directly to the laboratories that can execute the work. By combining AI with our established supplier network and legal infrastructure, we're removing the barriers that have traditionally slowed outsourced research.”

Connecting AI-Driven Scientific Discovery to Laboratory Execution

MCP connectivity also opens the door to direct agent-to-agent collaboration between biopharma companies and Scientist.com. A company's internal AI agents will be able to communicate directly with Scientist.com's agents to coordinate outsourced research, from identifying requirements and selecting laboratories to obtaining proposals and initiating purchases. Organizations can maintain human oversight at critical decision points, including supplier selection and financial commitments.

Looking ahead, these capabilities could enable a continuous cycle of AI-assisted experimental design, laboratory execution, and learning from experimental results to guide the next round of discovery.

Built for Enterprise Research Procurement

Scientist.com's AI agents operate within each organization's existing procurement framework, incorporating approved suppliers, spending limits, contractual requirements, and compliance policies. By automating routine purchasing activities while preserving enterprise oversight, the platform reduces administrative work, accelerates research execution, and allows scientists to focus on discovery.

Scientist.com

Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.

‍

We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.

‍

Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.

Share this press release